title: Chronic Myelogenous Leukemia After Therapy for Langerhans Cell Histiocytosis in an Adolescent.
authors.affiliation: Departments of *Pediatrics †Laboratory Medicine, School of Medicine Kyung Hee University, Seoul, Korea.
authors.forename: Hoi Soo
authors.initials: HS
authors.lastname: Yoon
authors.forename: Yong-Sung
authors.initials: YS
authors.lastname: Choi
authors.forename: Tae Sung
authors.initials: TS
authors.lastname: Park
mesh_terms: D000293:Adolescent; D000972:Antineoplastic Agents, Phytogenic / Q000627:therapeutic use; D016044:Fusion Proteins, bcr-abl / Q000235:genetics; D006646:Histiocytosis, Langerhans-Cell / Q000150:complications* / Q000188:drug therapy*; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000150:complications* / Q000235:genetics; D008297:Male; D011241:Prednisone / Q000627:therapeutic use; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014747:Vinblastine / Q000627:therapeutic use
chemical_list: D000972:Antineoplastic Agents, Phytogenic; D014747:Vinblastine; D016044:Fusion Proteins, bcr-abl; D011241:Prednisone